PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank43
3Y CAGR-27.0%
5Y CAGR-39.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-27.0%/yr
Annual compound
5Y CAGR
-39.4%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.63 | +41.8% |
| 2024 | 0.44 | -32.9% |
| 2023 | 0.66 | -59.1% |
| 2022 | 1.61 | -52.3% |
| 2021 | 3.38 | -55.9% |
| 2020 | 7.67 | +133.5% |
| 2019 | -22.89 | -831.0% |
| 2018 | -2.46 | - |